Published on 8 Aug 2021 on Benzinga via Yahoo Finance
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The...
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in, triggering stock-specific moves, while clinical readouts also moved stocks during the week.
BeyondSpring Inc. (NASDAQ: BYSI) was among the biggest biopharma gainers of the week, with the stock reacting to a positive late-stage readout for its lung cancer treatment combo. The stock ended the week with a gain of about 128%.
NASDAQ.DARE price evolution
NASDAQ.EVFM price evolution
NASDAQ.RETA price evolution
NASDAQ.RUBY price evolution
NASDAQ.AVDL price evolution
NASDAQ.VIRI price evolution
NASDAQ.ATRA price evolution
NASDAQ.AFIB price evolution
NASDAQ.AMPH price evolution
NASDAQ.APLS price evolution
NASDAQ.ONTX price evolution
NASDAQ.APTX price evolution
NASDAQ.AXSM price evolution
NASDAQ.ADMA price evolution
NASDAQ.ORGO price evolution
NASDAQ.BYSI price evolution
NASDAQ.RLMD price evolution
NASDAQ.OPGN price evolution
NASDAQ.LTCH price evolution
NASDAQ.PAVM price evolution
NYSE.AMRX price evolution
NASDAQ.XGN price evolution
NASDAQ.NVAX price evolution
Want to become a better investor?
Start tracking your investments with Statfolio
Sign up for free